Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 278,674.0 | $215.3M | 5.12% | +265K | +1900.8% | $772.64 | -15.9% |
| 2 | GILD | GILEAD SCIENCES INC | Healthcare | 1,169,879.0 | $163.0M | 3.88% | +1.1M | +2117.7% | $139.37 | -6.4% |
| 3 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 6,726,144.0 | $131.6M | 3.13% | +2.4M | +54.3% | $19.56 | -9.9% |
| 4 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 481,785.0 | $124.5M | 2.96% | +71K | +17.4% | $258.32 | +17.8% |
| 5 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 3,280,000.0 | $119.1M | 2.83% | +3.3M | +10000.0% | $36.32 | +2.1% |
| 6 | NUVL | NUVALENT INC | Healthcare | 1,053,268.0 | $107.9M | 2.57% | +16K | +1.5% | $102.45 | -1.2% |
| 7 | AMGN | AMGEN INC | Healthcare | 295,358.0 | $103.9M | 2.47% | +277K | +1497.5% | $351.85 | -4.1% |
| 8 | MDT | MEDTRONIC PLC | Healthcare | 957,329.0 | $83.0M | 1.97% | +191K | +24.9% | $86.65 | -9.8% |
| 9 | VERA | VERA THERAPEUTICS INC | Healthcare | 1,710,771.0 | $68.8M | 1.64% | +13K | +0.7% | $40.23 | -13.9% |
| 10 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2,380,000.0 | $49.9M | 1.19% | +2.4M | +10000.0% | $20.95 | +11.6% |
| 11 | JBIO | JADE BIOSCIENCES INC | Healthcare | 3,501,502.0 | $49.2M | 1.17% | +160K | +4.8% | $14.05 | +67.0% |
| 12 | DHR | DANAHER CORP DEL | Healthcare | 202,164.0 | $38.3M | 0.91% | +8K | +3.9% | $189.60 | -8.6% |
| 13 | MRK | MERCK & CO INC | Healthcare | 206,591.0 | $24.9M | 0.59% | +114K | +124.3% | $120.29 | -3.7% |
| 14 | TMDX | TRANSMEDICS GROUP INC | Healthcare | 101,139.0 | $10.1M | 0.24% | +3K | +3.3% | $99.41 | -31.6% |
| 15 | TXG | 10X GENOMICS INC | Healthcare | 329,492.0 | $7.0M | 0.17% | +7K | +2.3% | $21.23 | +13.0% |
| 16 | WAY | WAYSTAR HLDG CORP | Technology | 256,139.0 | $6.2M | 0.15% | +14K | +6.0% | $24.11 | -20.3% |
| 17 | MDLN | MEDLINE INC | Healthcare | 136,635.0 | $6.1M | 0.14% | +19K | +16.1% | $44.50 | -16.6% |
| 18 | PFE | PFIZER INC | Healthcare | 107,635.0 | $3.0M | 0.07% | +51K | +89.3% | $28.08 | -7.6% |
| 19 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 25,377.0 | $1.9M | 0.04% | +1K | +5.2% | $74.26 | -5.4% |
| 20 | RPRX | ROYALTY PHARMA PLC | Healthcare | 38,296.0 | $1.8M | 0.04% | +25K | +190.1% | $47.97 | +10.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.2%
Energy
0.1%
Financial Services
0.1%
Consumer Cyclical
0.0%
Communication Services
0.0%
Consumer Defensive
0.0%